BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive: S1g-2 (Figure 1, 5a) was identified as an inhibitor of Hsp70-Bim interaction (IC50 = 0.4 μM) in CML cells by screening a Bcl-2 inhibitor library [51].